References
- Grosheide P. Van Damme P. Prevention and control of hepatitis B in the community, WHO Viral Hepatitis Prevantion Board, Communnicable Diseasse Series No.1. 1996, Edegen, Belgium. 2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat 2004; 11(2):97-107
- Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005;2(1):50–7
- Mahoney FC. Update on diagnosis management and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351-66
- Update: Vaccine Side Effects, Adverse Reactions, Precautions Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45(RR- 12):1-35 and
- Lilic D, Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 1994; 344 (5):1292.
- Ballinger AB, Clark ML. Acute hepatitis B infection after vaccination. Lancet 1994;345:262
- Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ 2004;329;1080-86
- Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis Delta virus. In: Mandell GL, Douglas RG, Bennett JE (eds). Principles and practice of infectious disease. 6th ed. Philadelphia: Churchill Livingstone, 2005;1864-90
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
Yusuf Önlen¹
This is me
Lütfü Savaş
This is me
Burçin Özer
This is me
Nur Efe İris
This is me
Publication Date
December 1, 2006
Submission Date
April 27, 2015
Acceptance Date
-
Published in Issue
Year 2006 Volume: 3 Number: 4